|
Bricanyl contains terbutaline, a fast-onset but short-acting (4-6 hours)
ß2-agonist that has been widely used since its introduction in 1970.
Terbutaline acts within a few minutes of being inhaled, and is indicated
for the as needed treatment of bronchial asthma, as well as for other
lung diseases where bronchospasm is a complicating factor, such as chronic
bronchitis and emphysema.
The as needed use of inhaled terbutaline as a reliever for asthma is
well established in national and international guidelines.
|
